Telix Pharmaceuticals Limited Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Telix Pharmaceuticals Limited (TLPPF) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of 3.34 AUD/shares for the 12-month period ending 2024-12-31, per its 20-F filed 2025-02-24.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2025-02-24
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2024-12-31 | 3.34 AUD/shares 20-F · filed 2025-02-24 |
| 2023-12-31 | 2.68 AUD/shares 20-F · filed 2025-02-24 |